Congenital anomalies of the kidney and the urinary tract (CAKUT)

MM Rodriguez - Fetal and pediatric pathology, 2014 - Taylor & Francis
This article reviews the majority of Congenital Anomalies of the Kidney and Urinary Tract
(CAKUT) with emphasis in Pediatric Pathology describing and illustrating lesions as varied …

[HTML][HTML] Polycystic kidney disease, autosomal recessive

WE Sweeney, ED Avner - 2019 - europepmc.org
Autosomal recessive polycystic kidney disease (ARPKD) belongs to a group of congenital
hepatorenal fibrocystic syndromes and is a cause of significant renal and liver-related …

The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of …

A Solazzo, F Testa, S Giovanella, M Busutti, L Furci… - PLoS …, 2018 - journals.plos.org
Background and objectives ADPKD is erroneously perceived as a not rare condition, which
is mainly due to the repeated citation of a mistaken interpretation of old epidemiological …

Harmine mitigates LPS-induced acute kidney injury through inhibition of the TLR4-NF-κB/NLRP3 inflammasome signalling pathway in mice

X Niu, Q Yao, W Li, L Zang, W Li, J Zhao, F Liu… - European journal of …, 2019 - Elsevier
Acute kidney injury is a common clinical condition associated with increased morbidity and
mortality. It is essential to find effective drugs with low side effects in the treatment of acute …

[HTML][HTML] Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease

WE Sweeney, P Frost, ED Avner - World journal of nephrology, 2017 - ncbi.nlm.nih.gov
AIM To investigate the therapeutic potential of tesevatinib (TSV), a unique multi-kinase
inhibitor currently in Phase II clinical trials for autosomal dominant polycystic kidney disease …

PKD2/polycystin-2 induces autophagy by forming a complex with BECN1

D Peña-Oyarzun, M Rodriguez-Peña, F Burgos-Bravo… - Autophagy, 2021 - Taylor & Francis
Macroautophagy/autophagy is an intracellular process involved in the breakdown of
macromolecules and organelles. Recent studies have shown that PKD2/PC2/TRPP2 …

[HTML][HTML] The genetics of autosomal recessive polycystic kidney disease (ARPKD)

P Goggolidou, T Richards - Biochimica et Biophysica Acta (BBA)-Molecular …, 2022 - Elsevier
ARPKD is a genetically inherited kidney disease that manifests by bilateral enlargement of
cystic kidneys and liver fibrosis. It shows a range of severity, with 30% of individuals dying …

Molecular pathophysiology of autosomal recessive polycystic kidney disease

A Cordido, M Vizoso-Gonzalez… - International Journal of …, 2021 - mdpi.com
Autosomal recessive polycystic kidney disease (ARPKD) is a rare disorder and one of the
most severe forms of polycystic kidney disease, leading to end-stage renal disease (ESRD) …

Aberrant regulation of Notch3 signaling pathway in polycystic kidney disease

J Idowu, T Home, N Patel, B Magenheimer, PV Tran… - Scientific reports, 2018 - nature.com
Polycystic kidney disease (PKD) is a genetic disorder characterized by fluid-filled cysts in the
kidney and liver that ultimately leads to end-stage renal disease. Currently there is no …

Rationale, design and objectives of ARegPKD, a European ARPKD registry study

K Ebner, M Feldkoetter, G Ariceta, C Bergmann… - BMC nephrology, 2015 - Springer
Background Autosomal recessive polycystic kidney disease (ARPKD) is a rare but frequently
severe disorder that is typically characterized by cystic kidneys and congenital hepatic …